Filtered By:
Vaccination: Cancer Vaccines
Countries: Iran Health

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 96 results found since Jan 2013.

In vitro and in vivo Evidence on Intra-tumor Injection of Allogeneic Serum for Immunotherapy in a Mouse Model of Colon Cancer
Iran J Allergy Asthma Immunol. 2022 Oct 26;21(5):549-560. doi: 10.18502/ijaai.v21i5.11042.ABSTRACTIt is believed that preformed antibodies are responsible for blood transfusion reactions and transplant rejections. In order to remove a tumor, the tissue must be rejected. On the basis of transfusion reaction and transplantation immunology, we hypothesized that allogeneic serum can inhibit tumor growth when injected intra-tumor. Initially, an in vitro cytotoxicity test was conducted using the C57BL/6 serum (intact or decomplemented) in combination with the BALB/c-originating CT26 cell line. The CT26 cell line was used to esta...
Source: Iranian Journal of Allergy, Asthma and Immunology - November 7, 2022 Category: Allergy & Immunology Authors: Erfan Basirat Danial Dehghan Ardeshir Abbasi Nafiseh Pakravan Source Type: research

Designing and psychometric assessment of the scale of factors influencing HPV vaccine uptake behaviors in young adults
CONCLUSION: FI(HPV)VUBYA 8-factor scale has good validity and reliability among young Iranian adults. Due to its appropriate psychometric properties, this scale can be used on this population in future studies.PMID:36088331 | DOI:10.1186/s13027-022-00461-z
Source: Cancer Control - September 10, 2022 Category: Cancer & Oncology Authors: Soudabeh Yarmohammadi Mohtasham Ghaffari Yadollah Mehrabi Samira Mousavi Ali Ramezankhani Source Type: research

Influenza Vaccine Booster Stimulates Antibody Response in Beta Thalassemia Major Patients
Lab Med. 2022 Jul 18:lmac035. doi: 10.1093/labmed/lmac035. Online ahead of print.ABSTRACTThe aim of this study was to evaluate antibody response against influenza vaccine in beta thalassemia major patients from Iran. Thirty beta thalassemia major patients were enrolled and divided into three groups: single dose (group 1), double dose (group 2), and control (group 3). Seroconversion, seroprotection, and geometric mean titer (GMT) assays were performed through hemagglutination inhibition (HI) on days 0, 14, and 60. Based on the results, the level of antibody titer was increased in group 2. Two weeks after vaccination, seroco...
Source: Cancer Control - July 18, 2022 Category: Cancer & Oncology Authors: Maryam Sheikh Abbas Ahmadi-Vasmehjani Mohammad Reza Atashzar Mohammad Hadi Karbalaie Niya Arefeh Ebrahimian Rasoul Baharlou Source Type: research

Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies
CONCLUSION: To summarize, the results showed that the recombinant protein with the MontanideTM ISA- 71 adjuvant developed a more appropriate level of immunity than Alum adjuvant, so it might be used as a safe and reliable vaccine against H1N1 virus for further research.PMID:35317113 | PMC:PMC8917850 | DOI:10.22038/IJBMS.2021.57053.12716
Source: Cancer Control - March 23, 2022 Category: Cancer & Oncology Authors: Sara Zahmati Morteza Taghizadeh Setareh Haghighat Reza Jalalirad Mehdi Mahdavi Source Type: research

Death caused by covid-19 in top ten countries in Asia affected by covid-19 pandemic with special reference to Pakistan
Braz J Biol. 2021 Nov 26;83:e248281. doi: 10.1590/1519-6984.248281. eCollection 2021.ABSTRACTThe COVID-19 is a contagious viral disease, was first emerged in Wuhan, China in December 2019 and became the whole world on alert. The mortality rate in top most countries in Asia with special reference to Pakistan has been focused. Since February 26 to September 2020 the total confirmed cases and mortality rate was measured through Wikipedia and the notable journals. Iran is the only country having highest number of deaths (5.73%) followed by Indonesia (3.77%) while Saudi Arabia shows the lowest number of deaths as 1.39%. In Paki...
Source: Cancer Control - December 1, 2021 Category: Cancer & Oncology Authors: W Khan A A Khan J Khan N Khatoon S Arshad P De Los R íos Escalante Source Type: research